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Rupture of abdominal aortic aneurysm (AAA) is the
end-stage, catastrophic failure of the diseased aortic wall
and results in approximately 15,000 deaths per year in the
United States.1 AAA rupture occurs when the diseased
aortic wall degenerates to the point where its mechanical
strength is insufficient to sustain the pressure-induced
forces acting on it. Our laboratory has previously shown
that the mechanical strength of the aneurysm wall is
reduced to 50% of that of nonaneurysmal aorta.2 The pre-
cise mechanisms of this weakening are not yet known.
However, understanding aneurysm wall weakening is
important in the study of the natural history of AAA and
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Purpose: Our previous computer models suggested that intraluminal thrombus (ILT) within an abdominal aortic
aneurysm (AAA) attenuates oxygen diffusion to the AAA wall, possibly causing localized hypoxia and contributing to
wall weakening. The purpose of this work was to investigate this possibility.
Methods: In one arm of this study, patients with AAA were placed in one of two groups: (1) those with an ILT of 4-
mm or greater thickness on the anterior surface or (2) those with little (< 4 mm) or no ILT at this site. During surgi-
cal resection but before aortic cross-clamping, a needle-type polarographic partial pressure of oxygen (PO2) electrode
was inserted into the wall of the exposed AAA, and the PO2 was measured. The probe was advanced, and measurements
were made midway through the thrombus and in the lumen. Mural and mid-ILT PO2 measurements were normalized
by the intraluminal PO2 measurement to account for patient variability. In the second arm of this study, two AAA wall
specimens were obtained from two different sites of the same aneurysm at the time of surgical resection: group I spec-
imens had thick adherent ILT, and group II specimens had thinner or no adherent ILT. Nonaneurysmal tissue was also
obtained from the infrarenal aorta of organ donors. Specimens were subjected to histologic, immunohistochemical, and
tensile strength analyses to provide data on degree of inflammation (% area inflammatory cells), neovascularization
(number of capillaries per high-power field), and tensile strength (peak attainable load). Additional specimens were
subjected to Western blotting and immunohistochemistry for qualitative evaluation of expression of the cellular hypoxia
marker oxygen-regulated protein.
Results: The PO2 measured within the AAA wall in group I (n = 4) and group II (n = 7) patients was 18% ± 9% lumi-
nal value versus 60% ± 6% (mean ± SEM; P < .01). The normalized PO2 within the ILT of group I patients was 39% ±
10% (P = .08 with respect to the group I wall value). Group I tissue specimens showed greater inflammation (P < .05)
compared with both group II specimens and nonaneurysmal tissue: 2.9% ± 0.6% area (n = 7) versus 1.7% ± 0.3% area
(n = 7) versus 0.2% ± 0.1% area (n = 3), respectively. We found similar differences for neovascularization (number of
vessels/high-power field), but only group I versus control was significantly different (P < .05): 16.9 ± 1.6 (n = 7) vs
13.0 ± 2.3 (n = 7) vs 8.7 ± 2.0 (n = 3), respectively. Both Western blotting and immunohistochemistry results suggest
that oxygen-regulated protein is more abundantly expressed in group I versus group II specimens. Tensile strength of
group I specimens was significantly less (P < .05) than that for group II specimens: 138 ± 19 N/cm2 (n = 7) versus
216 ± 34 N/cm2 (n = 7), respectively.
Conclusion: Our results suggest that localized hypoxia occurs in regions of thicker ILT in AAA. This may lead to
increased, localized mural neovascularization and inflammation, as well as regional wall weakening. We conclude that
ILT may play an important role in the pathology and natural history of AAA. (J Vasc Surg 2001;34:291-9.)
may lead to new treatment modalities that could inhibit or
reverse the weakening process.
Studies have demonstrated microstructural derange-
ments in the aneurysm wall, providing a structural basis
behind the observed wall weakening associated with
AAA.3-6 These are thought to be caused by defective
extracellular matrix production associated with an
unknown genetic disorder7 or by the exuberant pro-
teolytic enzyme expression known to occur in AAA as
compared with nonaneurysmal aorta.4,8-11 Possible
sources of the proteolytic enzymes are inflammatory cells
found in the AAA wall10-14 or intraluminal thrombus
(ILT)15 or mural smooth muscle cells and fibroblasts acti-
vated in response to some stimuli associated with the dis-
ease process.
Because ILT is found in about 75% of all AAAs,16 we
have recently turned our attention to this structure and its
possible role in the pathogenesis of AAA.17,18 This work
has suggested that ILT alters the biophysical environment
of the AAA wall. In one study, computer modeling sug-
gested that ILT may result in attenuated oxygen flow from
the lumen to the underlying AAA wall.18 The purpose of
this work was to address the hypothesis that the presence
of ILT in AAA leads to various degrees of cellular hypoxia
and contributes to diminished wall strength. Indeed, clini-
cal studies have supported the direct relationship of ILT to
AAA rupture risk.19-22 We demonstrate here that the AAA
wall adjacent to a thick layer of ILT is weaker and exhibits
greater degrees of cellular hypoxia and inflammation with
respect to wall specimens from the same AAA but adjacent
to a thinner layer of ILT. This suggests that ILT may
indeed play an active role in the pathogenesis of AAA.
METHODS
Intraoperative measurement of partial pressure of
oxygen. In one arm of this study, patients with AAA were
placed in one of two groups on the basis of the thickness
of ILT at the apical anterior position: (1) those with an ILT
of 4-mm or greater thickness or (2) those with little 
(< 4 mm) or no ILT at this site. Before aortic cross-
clamping was performed, a custom-made, calibrated, 
needle-type, platinum-iridium, polarographic partial pres-
sure of oxygen (PO2) microelectrode (tip diameter 25 µm)
was inserted into the wall of the exposed AAA, and the
PO2 was measured. Guided by a 3.5-MHz ultrasound
probe covered with a sterile sleeve, the PO2 microelectrode
tip was advanced to points centrally within the thrombus
(in patients with ILT) and within the lumen, and the PO2
at these positions was measured. All measurements were
normalized by the intraluminal PO2 to correct for patient
variability.
Human aortic tissue. In a second arm of this study,
paired tissue samples were obtained during operation from
the anterior aspect of a separate set of AAA during surgi-
cal resection. Group I samples were obtained from the
region where preoperative computed tomography
revealed that ILT was thickest (usually at or near the
apex), and group II samples were obtained from a location
where ILT was thinnest or absent (usually distal to the
apex). Care was taken to leave any adherent ILT attached
to the AAA wall during harvest. ILT thickness was mea-
sured at three different positions for each sample, aver-
aged, and recorded. The ILT was then gently removed
from the AAA wall and discarded. Nonaneurysmal
infrarenal aortic wall tissue specimens were also obtained
from organ donors to serve as nonaneurysmal controls.
Most aortic wall samples were divided into a larger portion
and a smaller portion. The larger segment was placed in
saline solution for subsequent tensile testing, whereas the
smaller portion was fixed with 4% paraformaldehyde for
24 hours and cryoprotected with 2.3 mol/L sucrose
overnight. The fixed samples were then rapidly frozen
with liquid nitrogen in Tissue Freezing Medium (Triangle
Biomedical Sciences, Durham, NC) for subsequent histo-
logic and immunohistochemical analysis.
Immunohistochemistry. Six separate sections (10
µm) were cut from different layers through the aortic sam-
ples with a cryostat microtome and mounted on 0.5%
gelatin-coated slides. Immunohistochemistry was performed
with an immunofluorescence technique. Sections were
washed three times with a blocking solution of phosphate-
buffered saline solution containing 0.15% glycine and
0.5% bovine serum albumin, pH 7.4 (buffer A) to mini-
mize nonspecific binding of the primary and secondary
antibodies. Sections were then incubated with purified
goat immunoglobulin G (50 mg/mL) for 40 minutes at
25°C followed by three washes with buffer A, then incu-
bated for 60 minutes with the primary antibody to von
Willebrand factor (1:800 dilution; Sigma Chemical Co, St
Louis, Mo). This was followed by three washes in buffer A
and 60 minutes incubation with the secondary antibody
that was fluorescently tagged (Fluorophore Cy3, 1:3000
dilution; Sigma Chemical Co). Negative controls were
created from additional sections following the same pro-
cedure but with the primary antibody omitted. All sec-
tions were then washed with buffer A three times,
mounted in Gelvatol (Monsanto Corporation, St Louis,
Mo), secured with a coverslip, and examined under a
Nikon Microphot-FXL immunofluorescence microscope
(Nikon Corp, Tokyo, Japan).
From one additional set of group I and group II spec-
imens, serial sections were fluorescently labeled with anti-
bodies to oxygen-regulated protein (ORP)23,24 and
CD45. ORP is a 150-kD polypeptide recently found to be
expressed in human vascular tissue specifically in response
to hypoxia.23 CD45 was used to detect inflammatory cells.
Negative controls were included for both as above.
Counterstaining adjacent sections with Hoescht allowed
detection of biologic structures. Images from these sec-
tions were imported into Adobe Photoshop (version 5.5)
(Adobe Systems Inc, San Jose Calif) and combined, or 
layered, to allow qualitative evaluation of ORP staining
patterns.
Morphometric analysis. Six additional 10-µm cryo-
stat sections prepared as above were stained with hema-
toxylin and eosin (H&E) and examined with light
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microscopy. Digital images were collected directly by use
of a Nikon microscope with a 10× objective coupled to a
high-sensitivity, integrating three-chip Sony Color Video
Camera (Sony Corp, Park Ridge, NJ) (700 × 600 pixels).
Quantification of degree of inflammation was performed
by a blinded, standard “semiautomatic” quantification
technique that has been shown to be time efficient and
reliable.25 Images were imported directly to the image
analysis program NIH Image (version 1.61) (US National
Institutes of Health, Bethesda, Md). Each image was con-
verted to gray-scale, and then a threshold was applied at a
level that distinguished between the stained cells and the
unstained background under H&E to calculate the area
fraction of the inflammatory cells.26 We further “semiau-
tomatically” outlined the regions occupied by the smooth
muscle cells and fibroblasts as shown by their characteris-
tic appearance and then deleted this background staining
from the original image. Under the gray-scale, the pro-
portion of black to total pixels in the image was then cal-
culated as a percentage area occupied by inflammatory
cells per 100× field. Neovascularization within the
aneurysm wall was also quantified in a blinded manner by
counting the number of capillaries per 100× field.
Capillaries were defined as tubular structures containing
red blood cells and further confirmed by a positive stain-
ing to the endothelial-specific von Willebrand factor as
described above. Measures were averaged from three ran-
dom sites for each of the six different vessel sections per
aortic sample to reduce sampling error in the quantifica-
tion of both inflammation and neovascularization.
Tensile testing. Specimens designated for tensile test-
ing were cut into long, thin circumferential strips of tissue
and placed into a well-established tensile testing system as
previously described.27 The specimens were loaded along
their long axis until failure while the applied force and
resulting deformation were measured continuously. The
mechanical stress within the specimen at any given time
was calculated as previously described by normalizing the
applied force by cross-sectional area.27 The strength of
each specimen was taken as the peak stress obtained before
failure.
Western blotting. We obtained tissue from two addi-
tional AAA and one additional nonaneurysmal control for
immunoblotting. Without dividing the specimens, they
were processed as per the methods detailed above (see
“Human Aortic Tissue”). Western blotting was performed
as previously described.23 In brief, tissue specimens were
washed with phosphate-buffered saline solution and dis-
rupted by use of a Polytron homogenizer in buffer contain-
ing NP-40 (1%), EDTA (5 mmol/L), phenylmethyl-
sulfonyl fluoride (1 mmol/L), leupeptin (10 µg/mL), and
aprotinin (10 µg/mL) at 4°C. After acetone precipitation,
protein extracts (5 µg) were resuspended in phosphate-
buffered saline solution containing NP-40 (1%) and sepa-
rated in SDS-PAGE (8%). Protein content was adjusted
such that approximately the same amount of α-smooth
muscle actin was detected in each sample (total protein con-
tent was also comparable between samples), and the pres-
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ence of immunoreactive ORP was assessed by Western blot-
ting by use of anti-human ORP immunoglobulin G (5
µg/mL). For positive control, human cultured mononu-
clear cells (5 × 105 cells) were either exposed to hypoxia or
maintained in normoxic condition for 24 hours, and their
protein extracts (5 µg) were subjected to Western blot.
Statistical analysis. Quantitative results are pre-
sented as mean ± SEM. Comparisons of the PO2 mea-
surements between the two groups of patients was made
by use of the Student t test. Comparison of the paired
tensile strength data and ILT thickness measures was
made by use of the paired t test. All other quantitative
results were analyzed by use of analysis of variance and
the Student-Newman-Keuls method to perform ad hoc,
pairwise comparisons. Analysis was performed with a
statistical software package (Sigma Stat; Jandel
Scientific, San Raphael, Calif). P less than .05 was con-
sidered to be statistically significant.
RESULTS
A total of 11 patients were studied for PO2 measure-
ments: 4 who provided measurements associated with a
thick thrombus (group I; age 67.0 ± 5.8 years; maximum
AAA diameter 5.8 ± 0.5 cm), and 7 who provided mea-
surements associated with little or no thrombus (group II;
age 67.4 ± 6.0 years; maximum AAA diameter 6.0 ± 0.7
cm). There was no significant difference in either age or
maximum AAA diameter between the two groups of
patients. The data revealed a significantly lower PO2 in the
wall of group I AAA as compared with group II AAA: 18%
± 9% versus 60% ± 6%, respectively (Fig 1, A; P < .01). We
also found a marked PO2 gradient through the AAA with
ILT, with the PO2 highest in the lumen and lowest in the
AAA wall (Fig 1, B).
A total of seven separate patients (age 73.4 ± 2.4
years) with AAA (6.9 ± 0.7 cm maximum diameter) sup-
plied paired wall specimens for immunohistochemical,
morphometric, and tensile strength analyses. In addition,
nonaneurysmal control aortic specimens were obtained
from three donors (age 40.7 ± 6.8 years) for immunohis-
tochemical and morphometric analyses. The mean thick-
ness of the ILT attached to the group I tissue specimens
was significantly greater than the mean thickness of the
ILT attached to the group II tissue specimens: 16 ± 3 mm
versus 6 ± 2 mm, respectively (P < .005).
Representative aortic sections stained for von
Willebrand factor are shown in Fig 2. Fig 3 reveals a sig-
nificantly (P < .05) greater number of capillaries per high-
powered field in the group I AAA wall specimens adjacent
to thick ILT (16.9 ± 1.6, n = 7) as compared with non-
aneurysmal controls (8.7 ± 2.0, n = 3). There was no dif-
ference in number of capillaries in the group II AAA wall
specimen adjacent to thin or no ILT (13.0 ± 2.3, n = 7) as
compared with either the group I specimens or the non-
aneurysmal controls.
Representative H&E-stained aortic sections are shown in
Fig 4. As shown in Fig 5, we found a significantly (P < .05)
greater percentage area of inflammatory cells in the group I
AAA wall specimens adjacent to thick ILT (2.9% ± 0.6%, n =
7) as compared with both group II specimens adjacent to
thin or no ILT (1.7% ± 0.3%, n = 7) and nonaneurysmal con-
trols (0.2% ± 0.1%, n = 3). There was also a significant dif-
ference (P < .05) between the latter two groups.
Tissue sections stained with Hoescht stain and anti-
bodies to ORP and CD45 are shown in Fig 6. Western
blotting results for two separate group I and group II pairs
of specimens, as well as nonaneurysmal, positive, and neg-
ative controls are shown in Fig 7. Both immunohisto-
chemistry (Fig 6, A and B) and Western blotting analysis
(Fig 7) suggest, qualitatively, that ORP is found in AAA
sections and may be more abundantly expressed in regions
with thick ILT as compared with regions with thin ILT.
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Fig 2. Representative sections demonstrate neovascularization in group I and group II AAA wall specimens and in non-
aneurysmal control specimens. Capillaries are identified via positive staining for von Willebrand factor. Original magnifi-
cation × 200.
Fig 1. A, Comparison of in vivo PO2 measurements for AAA wall adjacent to thick ILT versus AAA wall adjacent to thin
or no ILT. B, In vivo measurements demonstrate PO2 gradient through thickness of AAA containing thick ILT. Note: all
measurements normalized to respective luminal PO2 value.
A
B
Immunohistochemistry results (Fig 6, D and E) also qual-
itatively agree with our quantitative assessment of degree
of inflammation (Fig 5).
Comparison between group I and group II tensile
strength measurements is shown in Fig 8. The group I
AAA wall specimens adjacent to thick ILT were signifi-
cantly weaker than group II specimens adjacent to thin or
no ILT (138 N/cm2 ± 19 N/cm2 vs 216 N/cm2 ± 34
N/cm2, P < .05).
DISCUSSION
In this article we examined the hypothesis that ILT in
AAA is associated with local hypoxia of the AAA wall. We
based this hypothesis on our earlier computational investi-
gation, which suggested that ILT attenuates oxygen flow
from the lumen to the AAA wall.18 We first performed
measurements within the AAA during operation by use of
a PO2 electrode, and these results support the notion that
the presence of ILT is associated with lower levels of mural
PO2 (Fig 1). Vascular tissue responds to hypoxic condi-
tions by initiating a series of events that lead to inflamma-
tion and neovascularization.14,21 Therefore, as an indirect
marker of hypoxia, we also examined the presence of
inflammatory cells and neovascularizaton within the AAA
wall. Although the differences that we measured with
regard to neovascularization are not significant (Fig 3), we
think that they demonstrate a trend that supports the
overall hypothesis that there do exist differences in the
pathobiologic condition of the AAA wall in the thick ILT
versus thin ILT regions. Our data demonstrate a signifi-
cant difference in neovascularization between group I
AAA tissue and the nonaneurysmal controls. That we
observed this, but not a difference between group I and
group II tissue, might indicate either that we did not ana-
lyze enough samples to detect differences or that both
group I and group II tissue have similar degrees of neo-
vascularization. The inflammation measurements also sup-
port our hypothesis (Figs 4 and 5), and these data are
qualitatively supported by comparison of Fig 6, D to E. As
a direct marker for cellular hypoxia, we also examined
qualitatively the protein expression of ORP, a hypoxia-
specific polypeptide known to be expressed by various
human cell types, including macrophages and smooth
muscle cells.23,24 These results also support our hypothe-
sis that ILT is associated with hypoxia (Figs 6 and 7). A
possible consequence of the hypoxia and subsequent
inflammation is local wall weakening (Fig 8).
The AAA wall weakening noted in association with
hypoxia might be caused by any combination of a number
of factors. For example, the increased number of inflam-
matory cells characteristic of these regions (Figs 4 and 5)
would increase the local proteolytic activity of the
wall.10,11,13 That these regions containing a large number
of inflammatory cells are also exposed to hypoxia may
exacerbate this situation. Macrophages exposed to hypoxia
exhibit enhanced bioreactivity,28-32 including an increase
in elastase production.33 We have recently shown that ILT
contains many living cells, including macrophages and
JOURNAL OF VASCULAR SURGERY
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neutrophils.15 Therefore another possibility is that the
regions of AAA wall adjacent to thicker layers of ILT are
exposed to proteolytic enzymes leeching from the ILT.
Indeed, Jean-Claude et al12 found elevated levels of plas-
min present in the inner layers of the AAA wall near the
interface with ILT, and this may be a possible conse-
quence of such leeching. Finally, elastin and collagen syn-
thesis by endothelial cells, smooth muscle cells (SMCs),
and fibroblasts is dependent on the availability of oxy-
gen.34-41 Aortic endothelial cells cultured in hypoxic con-
ditions exhibit a decrease in collagen synthesis,38 whereas
hypoxic arterial SMCs exhibit a decrease in both collagen
synthesis39,42 and tropoelastin mRNA expression and syn-
thesis.35 Fibroblasts exposed to hypoxic conditions also
produce less collagen.36,40 Furthermore, the collagen that
is synthesized by hypoxic cells is abnormal, because oxy-
gen is needed for the hydroxylation of proline.36
Therefore the extracellular matrix synthesis by the hypoxic
vascular wall is likely impaired or results in abnormal
matrix, and this would lead to wall weakening, which is
consistent with our findings.
AAA is not the only disease process that appears to
have decreased regional strength in association with local
hypoxia and inflammation. Lendon et al43 showed that the
mechanical strength of atherosclerotic plaque caps is
reduced with increased presence of macrophages. As with
ILT, atherosclerotic plaques appear to be associated with
patterns of hypoxia.23 Therefore, as we hypothesize above
for the AAA, the inverse relationship of plaque strength
and number of macrophages may be due to the stimula-
tion of these cells by the local hypoxic environment, caus-
ing them to release various proteolytic enzymes.
Our experimental in vivo measurements of PO2 in
the AAA wall are consistent with our previous estimates
with a computer model. Just as we showed here (Fig 1,
B), our previous computer model predicted a significant
gradient in PO2 through the ILT thickness, with maxi-
mum value at the luminal position, intermediate value at
Fig 3. Quantification of neovascularization in group I, group II,
and nonaneurysmal control specimens. Significant difference was
noted between both group I and group II specimens and con-
trols, but not between group I and group II.
a medial region, and lowest value at the AAA wall.18 Our
computer model also predicted an inverse relationship of
PO2 at the AAA wall with local ILT thickness, as we
demonstrated with our experimental measurements here
(Fig 1, A).
The presence of hypoxia within the AAA wall can be
intimately related to the marked inflammation and the dif-
ference in neovascularization that we also observed. A
hypoxic environment has been shown to stimulate both
SMCs and fibroblasts to secrete active angiogenic fac-
tors.34,35,44 Indeed, the potent angiogenic factor vascular
endothelial growth factor contains hypoxia regulatory ele-
ments in its gene and is highly stimulated by hypoxia both
in vitro and in vivo.45,46 More recently, Chiarugi et al47
have demonstrated that hypoxia induces a variety of angio-
genesis control factors, including p53, vascular endothelial
growth factor, inducible nitric oxide synthase, and
cyclooxygenase-2. The resultant neovascularization
induced by these factors can then serve as a route for
inflammatory cells to transmigrate to the media of AAA.
Neovascularization may be a compensatory response to
local hypoxia, serving as a route for delivery of the nutri-
ents and oxygen to the inflamed tissue. However, the
inflammatory cells may secrete proteolytic enzymes acting
to locally weaken the AAA wall.
Although this study does not distinguish the primary
etiologic events leading to aneurysm formation, it is clear
that wall hypoxia, inflammation, and possibly medial neo-
vascularization are closely associated in the AAA wall.
Others have made similar observations of a codependency
between angiogenesis and inflammation in AAA.14,48 In
addition to its primary angiogenic effect, hypoxia has been
shown to stimulate monocytes and macrophages to secrete
angiogenic factors.49,50 Even in an unstimulated state,
macrophages can produce a variety of cytokines and
growth factors to induce angiogenesis.14 Therefore
inflammatory cell infiltration within the hypoxic AAA wall
may enhance medial neovascularization.
As with all experimental work, this investigation has
some limitations that must be kept in mind when the data
are interpreted. For example, because the samples used for
tensile testing and microscopy were obtained from open
surgical resection of AAA, we were limited to tissue that
was easily removed, that is, that from the anterior surface.
As a result, the paired samples did not necessarily originate
from regions of comparable aortic diameter. It is possible
that the differences that are noted between group I and
group II specimens are due to these local diameter differ-
ences. Additionally, atherosclerosis is known to be associ-
ated with each of the pathologic changes that we have
noted here. However, because all AAA specimens were
paired (ie, each AAA served as its own control) and assum-
ing that both of the specimens from each pair were simi-
larly affected by atherosclerosis, the differences that were
observed between group I and group II specimens should
be primarily due to the difference in ILT thickness (ie,
hypoxia). Moreover, although the nonaneurysmal aortic
(control) specimens were not age-matched to the AAA tis-
sue, nearly all adult abdominal aorta has some degree of
atherosclerosis. As a result, differences noted between
group II AAA specimens and the nonaneurysmal aortic
tissue should be primarily due to the aneurysmal disease
process. Therefore, in spite of its limitations, the experi-
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Fig 4. Representative H&E sections demonstrate inflammatory cells in group I and group II AAA wall specimens and in
nonaneurysmal control specimens. Original magnification × 100.
Fig 5. Quantification of inflammation in group I, group II, and
nonaneurysmal control specimens. Significant difference was
noted among all groups.
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mental design used in this study allowed us to evaluate
AAA wall pathobiologic condition in association with ILT,
which was our goal.
In summary, our results suggest that hypoxia is pres-
ent in regions of AAA wall adjacent to thick ILT. This may
lead to increased localized inflammation and possibly neo-
vascularization at these sites and appears to result in local-
ized wall weakening. We conclude therefore that ILT may
play an important role in the pathology and natural his-
tory of AAA.
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Center for Biologic Imaging at the University of
Pittsburgh for their assistance with immunohistochem-
Fig 6. Serial immunohistochemistry sections for group I (A and D), group II (B and E), and primary-delete negative con-
trol (C and F) specimens stained with antibodies to ORP and CD45 and counterstained with Hoescht (A-C), or stained
with antibodies to CD45 alone (D-F). Hoescht-stained nuclei appear blue, whereas ORP-positive cells appear green and
CD45-positive cells appear red. Long arrows indicate representative colocalization of ORP- and CD45-positive cells,
whereas arrowheads indicate representative cells that are ORP-positive only. Unspecific signal in negative control (C and
F) is likely due to autofluorescence of elastin in tissue sections. Original magnification × 100.
Fig 7. Western blot for 150-kDa ORP in two different (A and B)
group I–group II pairs of AAA wall specimens, nonaneurysmal
control (DON), positive control of hypoxic macrophages (MPs)
in culture, and negative control of normoxic macrophages in cul-
ture. Molecular weight markers correspond to ovalbumin (46
kDa), bovine serum albumin (66 kDa), phosphorylase b (97.4
kDa), beta-galactosidase (116 kDa), and myosin (200 kDa).
Greater signal was detected in both group I specimens as com-
pared with their paired group II specimen, and also as compared
with nonaneurysmal control specimen.
Fig 8. Comparison of tensile strength for group I versus group II
specimens. Significant difference was noted by means of the
paired t test.
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